PedAM
Pediatric Disease Annotations & Medicines
| Disease | leukemia |
| Phenotype | C0026946|fungal infection |
| Sentences | 10 |
| PubMedID- 25049247 | Posaconazole tablets, a new oral formulation of posaconazole, can be effective when given as antifungal prophylaxis to neutropenic patients at high risk for invasive fungal infection (e.g., those with acute myelogenous leukemia or myelodysplastic syndrome). |
| PubMedID- 22215390 | [itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia]. |
| PubMedID- 26125209 | Rare angioinvasive fungal infection in association with leukemia cutis. |
| PubMedID- 23152759 | C. tropicalis is considered the leading pathogen in nosocomial fungemia and hepatosplenic fungal infections in patients with cancer, especially leukemia [13], [14]. |
| PubMedID- 20463605 | Successful nonmyeloablative allogeneic stem cell transplantation for therapy-related acute myelogenous leukemia in a patient with preexisting visceral fungal infection. |
| PubMedID- 21931981 | In this review, the role of secondary antifungal prophylaxis (sap) in prevention of invasive fungal infections (ifis) in patients with leukemia and in those receiving allogeneic hematopoietic stem cell transplantation (allo-hsct) is discussed. |
| PubMedID- 25913290 | Objective: rapid and effective treatment of invasive fungal infection (ifi) in patients with leukemia is important for survival. |
| PubMedID- 26188835 | Purpose: posaconazole is effective for the prophylaxis of invasive fungal infections (ifis) in patients with acute myeloid leukemia or myelodysplastic syndrome during remission induction chemotherapy. |
| PubMedID- 23042005 | Mucormycosis is an increasingly recognized invasive fungal infection (ifi) in patients with acute myeloid leukemia (aml) and after allogeneic (allo) stem cell transplantation (hsct); it is mainly due to the severe and prolonged neutropenia related to high-dose chemotherapy. |
| PubMedID- 25440778 | Invasive fungal infections in children with acute lymphoblastic leukemia have been a major cause of mortality. |
Page: 1